Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)

NCT05603065 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Tislelizumab + cisplatin + paclitaxel
DRUG: Tislelizumab + radiotherapy

Sponsor

First Affiliated Hospital Xi'an Jiaotong University